MedPath

Study on whether addition of heparin during cataract surgery will decrease inflammation after surgery

Phase 1
Conditions
Health Condition 1: H259- Unspecified age-related cataract
Registration Number
CTRI/2020/04/024817
Lead Sponsor
DR ABHISHEK G
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

cause of vision being cataract

Exclusion Criteria

patients with uveitis & glaucoma

patients with traumatic cataract, complicated cataract, congenital cataract.

patients who have undergone surgeries in the past.

ocular trauma

pupil size less than 7mm

patients on pilocarpine

patients with bleeding tendencies

patients on systemic anticoagulants

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
to document, grade and compare anterior chamber cells and flareTimepoint: to document, grade and compare anterior chamber cells and flare post day 1, 4weeks and 8 weeks postoperatively
Secondary Outcome Measures
NameTimeMethod
reduction in postoperative complications like posterior synechiae and cystoid macular edema.Timepoint: 3 years
© Copyright 2025. All Rights Reserved by MedPath